Chain Drug Review - Proscar changes
The FDA has approved Proscar (finasteride) combined with doxazosin for reducing the risk of benign prostatic hyperplasia symptoms. The brand name prescription product is marketed by Merck & Co.
Related Results
Four strengths of doxazosin approvedTeva, Apotex gain approval for doxazosinDoxazosin helps fight metabolic syndromeIvax receives tentative approval for doxazosin mesylate tabletsFinasteride and doxazosin combo halts BPH progress in 67%
COPYRIGHT 2004 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
